Literature DB >> 4218163

[Ticarcillin: in-vitro activity and pharmacokinetics (author's transl)].

C Simon, M Leuth, V Malerczyk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4218163     DOI： 10.1055/s-0028-1108155

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  5 in total

1.  [Therapy with cefotaxime-cefotaxime/ticarcillin for bronchopulmonary infections in patients under intensive care. (author's transl)].

Authors:  C D Schwigon
Journal:  Infection       Date:  1982       Impact factor: 3.553

2.  Ticarcillin serum and tissue concentrations in gynecology and obstetrics.

Authors:  D von Kobyletzki; A Dalhoff; H Lindemeyer; C A Primavesi
Journal:  Infection       Date:  1983 May-Jun       Impact factor: 3.553

3.  [Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].

Authors:  A Bauernfeind; C Petermüller; M Dietzel
Journal:  Infection       Date:  1979       Impact factor: 3.553

4.  In vitro activity of ticarcillin against anaerobic bacteria compared with that of carbenicillin and penicillin.

Authors:  I Roy; V Bach; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

5.  Ticarcillin concentrations in serum, muscle, and fat after a single intravenous injection.

Authors:  F D Daschner; G Thoma; H Langmaack; A Dalhoff
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.